XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - CAD ($)
$ in Millions
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities    
Earnings $ 1,837 $ 2,186
Adjustments to reconcile earnings to net cash provided by operating activities:    
Depreciation and amortization 1,653 1,540
Deferred income tax (recovery)/expense (328) 416
Changes in unrealized (gain)/loss on derivative instruments, net (Note 11) 549 (898)
Earnings from equity investments (698) (472)
Distributions from equity investments 732 513
Asset impairment 1,072 0
(Gain)/loss on dispositions 11 (83)
Other 110 48
Changes in operating assets and liabilities 1,600 497
Net cash provided by operating activities 6,538 3,747
Investing activities    
Capital expenditures (3,243) (3,922)
Long-term investments (592) (2,778)
Distributions from equity investments in excess of cumulative earnings (Note 7) 1,140 39
Additions to intangible assets (425) (463)
Cash acquired in Merger Transaction 0 681
Proceeds from dispositions 4 442
Reimbursement of capital expenditures 0 212
Other (23) (40)
Net cash used in investing activities (3,139) (5,829)
Financing activities    
Net change in short-term borrowings (433) 253
Net change in commercial paper and credit facility draws (2,166) 1,773
Debenture and term note issues, net of issue costs 3,537 3,175
Debenture and term note repayments (2,147) (2,184)
Purchase of interest in consolidated subsidiary 0 (227)
Contributions from noncontrolling interests 21 453
Distributions to noncontrolling interests (425) (466)
Contributions from redeemable noncontrolling interests 41 600
Distributions to redeemable noncontrolling interests (174) (117)
Common shares issued 14 9
Preference share dividends (174) (164)
Common share dividends (1,493) (1,427)
Net cash provided by/(used in) financing activities (3,399) 1,678
Effect of translation of foreign denominated cash and cash equivalents and restricted cash 35 (32)
Net increase/(decrease) in cash and cash equivalents and restricted cash 35 (436)
Cash and cash equivalents and restricted cash at beginning of period 587 1,562
Cash and cash equivalents and restricted cash at end of period $ 622 $ 1,126